Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$1.33B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$781M |
| 3 |
Tesla
TSLA
|
+$468M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$467M |
| 5 |
Home Depot
HD
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.36B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$860M |
| 3 |
Bank of America
BAC
|
+$413M |
| 4 |
Advanced Micro Devices
AMD
|
+$283M |
| 5 |
Salesforce
CRM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.2% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Communication Services | 1.89% |
| 4 | Healthcare | 1.12% |
| 5 | Financials | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9101
PUT
Ocular Therapeutix
OCUL
$2.38B
| $98K | ﹤0.01% |
24,800
-10,700
| -30% | -$37.2K |
|
9102
CALL
Opko Health
OPK
$1.12B
| $98K | ﹤0.01% |
66,400
-62,900
| -49% | -$105K |
|
|
STKL
9103
DELISTED
SunOpta
STKL
| $98K | ﹤0.01% |
39,021
+21,422
| +122% | +$47.7K |
|
|
MCF
9104
CALL
DELISTED
Contango Oil & Gas Co.
MCF
| $98K | ﹤0.01% |
26,800
-12,700
| -32% | -$37.3K |
|
9105
PUT
CEMIG Preferred Shares
CIG
$5.75B
| $97K | ﹤0.01% |
+55,715
| New | +$91K |
|
9106
CALL
Globalstar
GSAT
$10.6B
| $97K | ﹤0.01% |
12,507
+2,434
| +24% | +$14.7K |
|
|
AHT
9107
Ashford Hospitality Trust
AHT
$21.7M
| $96K | ﹤0.01% |
34
-89
| -72% | -$249K |
|
|
FPI
9108
PUT
Farmland Partners
FPI
$452M
| $96K | ﹤0.01% |
14,100
-29,100
| -67% | -$192K |
|
9109
IDEAYA Biosciences
IDYA
$4.01B
| $96K | ﹤0.01% |
+12,738
| New | +$90.9K |
|
|
BLCM
9110
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $96K | ﹤0.01% |
7,461
+6,407
| +608% | +$59.1K |
|
9111
Century Casinos
CNTY
$35.5M
| $95K | ﹤0.01% |
12,024
-25,434
| -68% | -$198K |
|
|
IGR
9112
CBRE Global Real Estate Income Fund
IGR
$707M
| $95K | ﹤0.01% |
+11,830
| New | +$93.8K |
|
9113
CALL
Corbus Pharmaceuticals
CRBP
$220M
| $94K | ﹤0.01% |
577
-3,100
| -84% | -$458K |
|
|
NPKI
9114
NPK International
NPKI
$1.11B
| $94K | ﹤0.01% |
14,945
-33,267
| -69% | -$217K |
|
|
HWCC
9115
PUT
DELISTED
Houston Wire & Cable Company
HWCC
| $94K | ﹤0.01% |
21,300
+1,000
| +5% | +$4.1K |
|
9116
PUT
Martin Midstream Partners
MMLP
$89.2M
| $93K | ﹤0.01% |
23,000
-29,100
| -56% | -$127K |
|
9117
CALL
Ring Energy
REI
$370M
| $93K | ﹤0.01% |
+35,300
| New | +$69.3K |
|
|
ACHN
9118
DELISTED
Achillion Pharmaceuticals
ACHN
| $93K | ﹤0.01% |
15,357
-57,180
| -79% | -$331K |
|
|
MDR
9119
DELISTED
McDermott International
MDR
| $93K | ﹤0.01% |
136,773
-2,777,052
| -95% | -$3.55M |
|
9120
CALL
Banco Bilbao Vizcaya Argentaria
BBVA
$160B
| $92K | ﹤0.01% |
+16,400
| New | +$87.3K |
|
9121
TeraWulf
WULF
$8.02B
| $92K | ﹤0.01% |
17,210
+148
| +0.9% | +$852 |
|
9122
Metallus
MTUS
$804M
| $92K | ﹤0.01% |
11,683
-9,304
| -44% | -$58.3K |
|
|
CMRX
9123
DELISTED
Chimerix, Inc.
CMRX
| $92K | ﹤0.01% |
45,236
+16,223
| +56% | +$29.9K |
|
|
CDR
9124
DELISTED
Cedar Realty Trust, Inc
CDR
| $92K | ﹤0.01% |
4,723
-3,800
| -45% | -$73.8K |
|
|
PTE
9125
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $92K | ﹤0.01% |
1,421
-2,831
| -67% | -$204K |
|
Similar funds
Jeff Yass's Q4 2019 Portfolio in Review
As of Q4 2019, Jeff Yass held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass deployed $12.7B of net new capital in Q4 2019, opening 1,232 new positions and adding to 3,827 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Amazon, an estimated $1.36B trimmed.
- Jeff Yass's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
- Jeff Yass added most to Boeing in Q4 2019, an estimated $1.33B increase.
- Jeff Yass's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
- Jeff Yass fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
- Jeff Yass's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
- Jeff Yass opened 1,232 new positions and closed 1,709 in Q4 2019.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $347B.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.